Why the study?
Cardiovascular disease remains the leading contributor to global morbidity and mortality, and understanding gut bacterial-mediated mechanisms may enable innovative microbiome-based preventive and therapeutic strategies.
Design
Comprehensive review
Authors
Loading...
May inform microbiome-targeted CVD strategies; leaves open whether modulating dysbiosis improves outcomes.
Key points are not available for this paper at this time.
Akter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: